The diazepine-based bromodomain and extra-terminal protein (BET) inhibitor JQ1 suppressed functional MYB-p300 in AML cells by inhibition of the reader protein bromodomain-containing protein 4 (BRD4)[201]. The gene discussed is EP300; the disease is acute myeloid leukemia.